Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Efficacy of an adenovirus-based anti-cocaine vaccine to reduce cocaine self-administration and reacqusition using a choice procedure in rhesus macaques.

Evans SM, Foltin RW, Hicks MJ, Rosenberg JB, De BP, Janda KD, Kaminsky SM, Crystal RG.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:76-86. doi: 10.1016/j.pbb.2016.09.008.

PMID:
27697554
2.

The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.

Wegmann F, Moghaddam AE, Schiffner T, Gartlan KH, Powell TJ, Russell RA, Baart M, Carrow EW, Sattentau QJ.

Clin Vaccine Immunol. 2015 Sep;22(9):1004-12. doi: 10.1128/CVI.00736-14.

3.

Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.

Miller ML, Aarde SM, Moreno AY, Creehan KM, Janda KD, Taffe MA.

Drug Alcohol Depend. 2015 Aug 1;153:29-36. doi: 10.1016/j.drugalcdep.2015.06.014.

4.

Flagellin as carrier and adjuvant in cocaine vaccine development.

Lockner JW, Eubanks LM, Choi JL, Lively JM, Schlosburg JE, Collins KC, Globisch D, Rosenfeld-Gunn RJ, Wilson IA, Janda KD.

Mol Pharm. 2015 Feb 2;12(2):653-62. doi: 10.1021/mp500520r.

5.

Vaccines against drugs of abuse: where are we now?

Kinsey B.

Ther Adv Vaccines. 2014 Jul;2(4):106-17. doi: 10.1177/2051013614537818. Review.

6.

The future potential for cocaine vaccines.

Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RA, Ramakrishnan M, Wang HY, Kosten TR.

Expert Opin Biol Ther. 2014 Sep;14(9):1271-83. doi: 10.1517/14712598.2014.920319. Review.

7.

Fate of systemically administered cocaine in nonhuman primates treated with the dAd5GNE anticocaine vaccine.

Hicks MJ, Kaminsky SM, De BP, Rosenberg JB, Evans SM, Foltin RW, Andrenyak DM, Moody DE, Koob GF, Janda KD, Ricart Arbona RJ, Lepherd ML, Crystal RG.

Hum Gene Ther Clin Dev. 2014 Mar;25(1):40-9. doi: 10.1089/humc.2013.231.

8.

Adenovirus: the first effective in vivo gene delivery vector.

Crystal RG.

Hum Gene Ther. 2014 Jan;25(1):3-11. doi: 10.1089/hum.2013.2527. Review. No abstract available.

9.

Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter.

Maoz A, Hicks MJ, Vallabhjosula S, Synan M, Kothari PJ, Dyke JP, Ballon DJ, Kaminsky SM, De BP, Rosenberg JB, Martinez D, Koob GF, Janda KD, Crystal RG.

Neuropsychopharmacology. 2013 Oct;38(11):2170-8. doi: 10.1038/npp.2013.114.

10.

Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.

De BP, Pagovich OE, Hicks MJ, Rosenberg JB, Moreno AY, Janda KD, Koob GF, Worgall S, Kaminsky SM, Sondhi D, Crystal RG.

Hum Gene Ther. 2013 Jan;24(1):58-66. doi: 10.1089/hum.2012.163.

11.

A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Miller ML, Moreno AY, Aarde SM, Creehan KM, Vandewater SA, Vaillancourt BD, Wright MJ Jr, Janda KD, Taffe MA.

Biol Psychiatry. 2013 Apr 15;73(8):721-8. doi: 10.1016/j.biopsych.2012.09.010.

12.

Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.

Carroll ME, Zlebnik NE, Anker JJ, Kosten TR, Orson FM, Shen X, Kinsey B, Parks RJ, Gao Y, Brimijoin S.

PLoS One. 2012;7(8):e43536. doi: 10.1371/journal.pone.0043536.

13.

Rational development of addiction pharmacotherapies: successes, failures, and prospects.

Pierce RC, O'Brien CP, Kenny PJ, Vanderschuren LJ.

Cold Spring Harb Perspect Med. 2012 Jun;2(6):a012880. doi: 10.1101/cshperspect.a012880. Review.

14.

AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.

Rosenberg JB, Hicks MJ, De BP, Pagovich O, Frenk E, Janda KD, Wee S, Koob GF, Hackett NR, Kaminsky SM, Worgall S, Tignor N, Mezey JG, Crystal RG.

Hum Gene Ther. 2012 May;23(5):451-9. doi: 10.1089/hum.2011.178.

15.

Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.

Koob G, Hicks MJ, Wee S, Rosenberg JB, De BP, Kaminsky SM, Moreno A, Janda KD, Crystal RG.

CNS Neurol Disord Drug Targets. 2011 Dec;10(8):899-904. Review.

17.

Thinking outside the synapse: pharmacokinetic-based medications for cocaine addiction.

Czoty PW, Roberts DC.

Neuropsychopharmacology. 2012 Apr;37(5):1079-80. doi: 10.1038/npp.2011.269. No abstract available.

Items per page

Supplemental Content

Support Center